Jul . 22, 2025 05:01 Back to list
The veterinary pharmaceutical landscape has witnessed revolutionary advancements in powder formulations, with veterinary powder products becoming indispensable in modern animal healthcare. This comprehensive analysis examines the scientific foundations, clinical applications, and quality standards defining today's veterinary wound powder, nutritional supplements, and therapeutic formulations.
Manufactured at GMP-certified facilities, Shijiazhuang Shimu Pharmaceutical Co., Ltd. provides premium pharmaceutical solutions compliant with international veterinary standards.
COMPOSITION: Each gram contains Neomycin 50mg
INDICATIONS: Aminoglycoside antibiotics effective against Gram-negative bacteria including E. coli and Salmonella, clinically proven for treatment of colibacillosis and pullorum disease.
View Product SpecificationsParameter | Wound Powder | Calcium Powder | Digestive Powder | Antibiotic Powder |
---|---|---|---|---|
Particle Size (μm) | 15-25 | 20-40 | 30-50 | 10-20 |
Solubility Rate | Low | High | Medium | High |
pH Range | 6.8-7.5 | 6.5-7.2 | 7.0-8.0 | 5.5-6.5 |
Moisture Content (%) | <3% | <2% | <4% | <2.5% |
Shelf Life | 24 months | 36 months | 18 months | 24 months |
Specialized veterinary wound powder formulations create optimal healing environments through moisture control, microbial barrier formation, and tissue regeneration enhancement.
Calcium powder for veterinary applications provides essential mineral support during growth phases, lactation periods, and bone development stages across multiple species.
Advanced digester powder veterinary formulations contain enzyme complexes that optimize nutrient absorption and gastrointestinal function in production animals.
Optimal particle distribution between 10-50μm ensures proper adhesion to moist surfaces while preventing particle agglomeration. Our GMP facilities utilize laser diffraction analysis for precise particle sizing.
Powder formulations require moisture content below 3% with specialized desiccants in packaging. Critical water activity levels below 0.6 aw prevent microbial growth and chemical degradation.
We implement HPLC-UV quantification with forced degradation studies, accelerated stability testing (40°C/75% RH), and bioequivalence trials following EMA and FDA-CVM guidelines.
Pharmaceutical-grade solubilizers including poloxamers, cyclodextrins, and surface-active agents increase dissolution rates while maintaining excipient safety profiles for veterinary applications.
Triple-layer aluminized pouches with oxygen scavengers maintain product integrity. Our moisture barrier technology ensures less than 0.01% water vapor transmission over 24 months.
Research & Manufacturing Center:
South District of Shangzhuang Industry Zone, Shijiazhuang, Hebei, China
Quality Assurance:
ISO 9001:2015, GMP, and FDA-CVM compliant manufacturing
Pharmaceutical Consultation: +86 311 6726 7356
Technical Documentation: shimu@sjzsm.com
Visit Product PortfolioProducts categories